Dr. James Brown, COO, REGENX, Elected to SAFE-BioPharma Board of Directors

FT. LEE, N.J.--()--SAFE-BioPharma Association, the non-profit collaboration that developed and manages the global SAFE-BioPharma® digital identity and digital signature standard, has elected James W. Brown, Ph.D., Chief Operating Officer, REGENX Biosciences, to its Board of Directors.

The SAFE-BioPharma standard is used throughout the biopharmaceutical and healthcare industries to manage digital identity trust and to apply legally binding digital signatures to electronic documents. It is a strategic initiative of the life sciences industry to facilitate secure, trusted and fully electronic business and regulatory processes. The association’s members include most of the world’s largest biopharmaceutical companies.

Based in Washington, D.C., REGENX is a personalized gene therapy company focused on unmet needs of a variety of severe diseases. Before joining REGENX, Dr. Brown was responsible for IT strategy and project portfolio for R&D at MedImmune. He also served in a variety of IT leadership roles in other life science companies. Earlier in his career, Dr. Brown was a National Research Council Postdoctoral Fellow at the National Institutes of Standards and Technology (NIST). He received his Ph.D. in Biophysical Chemistry from Stanford University and a B.S. in chemistry from Butler University.

SAFE-BioPharma Association has an all-volunteer Board which determines the association's strategic direction and business model, and oversees its management. Among numerous recent initiatives are global expansion of the standard through integration with biopharmaceutical and healthcare industry applications such as signing engines, portal providers, clinical trial applications, ePrescribing, access to eHRs, and other critical digital workflows.

“We welcome James Brown and his extensive R&D information technology experience. He will be an important asset to the future of SAFE-BioPharma," said Mollie Shields-Uehling, president and CEO and a director of SAFE-BioPharma Association.

About SAFE-BioPharma

For more information on the SAFE-BioPharma standard for digital identity and digital signatures used in life science and healthcare settings, visit http://www.safe-biopharma.org.

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

Contacts

SAFE-BioPharma Association
Jon Weisberg, 801-359-9977
jweisberg@safe-biopharma.org
cell: 801-860-9977

Sharing

Contacts

SAFE-BioPharma Association
Jon Weisberg, 801-359-9977
jweisberg@safe-biopharma.org
cell: 801-860-9977